Loading stock data…
SYK
$330.52-2.19 (-0.66%)
Market ClosedLast close Jun 29
Stryker Corporation operates as a medical technology company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Stryker Corporation in the Healthcare sector is trading at $330.52 with a market capitalization of $118.1B. Wall Street consensus targets $386.80 (25 analysts), implying a +17.0% move over the next 12 months. The stock is currently 18% below its 52-week high of $404.87, remaining 4.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +17.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.02B↓ | $7.17B↑ | $6.06B↑ | $6.02B↑ | $5.87B |
| Gross Profit | $3.81B↓ | $4.63B↑ | $3.85B↑ | $3.84B↑ | $3.74B |
| Operating Income | $936.00M↓ | $1.81B↑ | $1.21B↑ | $1.17B↑ | $872.00M |
| Net Income | $745.00M↓ | $849.00M↓ | $859.00M↓ | $884.00M↑ | $654.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$118.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.04%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.52%
Volume
Today's trading volume
2.04M
Recent News
Is Stryker Corporation (SYK) A Good Stock To Buy Now?
Is SYK a good stock to buy? We came across a bullish thesis on Stryker Corporation on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on SYK. Stryker Corporation’s share was trading at $313.68 as of June 24th. SYK’s trailing and forward P/E were 36.31 and 20.92 respectively according to Yahoo […]
Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?
Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Stryker Corporation (SYK) launches TPX HD® Power Tool
Stryker Corporation (NYSE:SYK) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds. On June 2, Stryker Corporation (NYSE:SYK) announced the launch of TPX HD. It is a small bone power tool designed for demanding orthopaedic procedures, including total joint revisions, minimally invasive surgery, and oral maxillofacial procedures. Mike Carlin, […]
Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss
Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy right now. On June 5, Leerink reduced its price target for Stryker Corporation (NYSE:SYK) to $407 from $410 while keeping an Outperform rating on the company’s stock. The firm changed its SYK model in response to new 10-Q filings following the company’s first-quarter 2026 […]
What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks
Stryker Corp. (NYSE:SYK) is one of the 10 best robotics and automation stocks to invest in. On May 26, Stryker Corp. (NYSE:SYK) introduced its Pangea Plating System to the European market. This hardware platform is built to treat many different types of bone fracture patterns. Orthopedic trauma surgeon at St. George’s University Hospital in London, […]